nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM5—eye—autistic disorder	0.0173	0.0747	CbGeAlD
Trihexyphenidyl—CHRM4—head—autistic disorder	0.0126	0.0542	CbGeAlD
Trihexyphenidyl—CHRM4—nervous system—autistic disorder	0.0119	0.0514	CbGeAlD
Trihexyphenidyl—CHRM2—forebrain—autistic disorder	0.0118	0.0508	CbGeAlD
Trihexyphenidyl—CHRM4—central nervous system—autistic disorder	0.0115	0.0495	CbGeAlD
Trihexyphenidyl—CHRM2—telencephalon—autistic disorder	0.0108	0.0467	CbGeAlD
Trihexyphenidyl—CHRM1—forebrain—autistic disorder	0.0107	0.0462	CbGeAlD
Trihexyphenidyl—CHRM1—telencephalon—autistic disorder	0.00987	0.0425	CbGeAlD
Trihexyphenidyl—CHRM5—head—autistic disorder	0.00983	0.0424	CbGeAlD
Trihexyphenidyl—CHRM3—forebrain—autistic disorder	0.0096	0.0414	CbGeAlD
Trihexyphenidyl—CHRM5—nervous system—autistic disorder	0.00932	0.0402	CbGeAlD
Trihexyphenidyl—CHRM4—brain—autistic disorder	0.00912	0.0393	CbGeAlD
Trihexyphenidyl—CHRM5—central nervous system—autistic disorder	0.00897	0.0387	CbGeAlD
Trihexyphenidyl—CHRM3—telencephalon—autistic disorder	0.00883	0.0381	CbGeAlD
Trihexyphenidyl—CHRM5—brain—autistic disorder	0.00713	0.0307	CbGeAlD
Trihexyphenidyl—CHRM2—head—autistic disorder	0.00675	0.0291	CbGeAlD
Trihexyphenidyl—CHRM3—digestive system—autistic disorder	0.00674	0.029	CbGeAlD
Trihexyphenidyl—CHRM2—nervous system—autistic disorder	0.0064	0.0276	CbGeAlD
Trihexyphenidyl—CHRM2—central nervous system—autistic disorder	0.00616	0.0266	CbGeAlD
Trihexyphenidyl—CHRM1—head—autistic disorder	0.00614	0.0265	CbGeAlD
Trihexyphenidyl—CHRM1—nervous system—autistic disorder	0.00582	0.0251	CbGeAlD
Trihexyphenidyl—CHRM1—central nervous system—autistic disorder	0.00561	0.0242	CbGeAlD
Trihexyphenidyl—CHRM3—head—autistic disorder	0.0055	0.0237	CbGeAlD
Trihexyphenidyl—CHRM3—nervous system—autistic disorder	0.00521	0.0225	CbGeAlD
Trihexyphenidyl—CHRM3—central nervous system—autistic disorder	0.00502	0.0216	CbGeAlD
Trihexyphenidyl—CHRM2—brain—autistic disorder	0.00489	0.0211	CbGeAlD
Trihexyphenidyl—CHRM1—brain—autistic disorder	0.00445	0.0192	CbGeAlD
Trihexyphenidyl—CHRM3—brain—autistic disorder	0.00398	0.0172	CbGeAlD
Trihexyphenidyl—CHRM3—Signaling Pathways—OXTR—autistic disorder	0.000172	0.000224	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—POMC—autistic disorder	0.000172	0.000224	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PRKCB—autistic disorder	0.000172	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL5—autistic disorder	0.000171	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SCT—autistic disorder	0.000171	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—OXTR—autistic disorder	0.000171	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SCT—autistic disorder	0.00017	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CALCA—autistic disorder	0.000169	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADRB2—autistic disorder	0.000169	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SCT—autistic disorder	0.000169	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADRB2—autistic disorder	0.000168	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—IL6—autistic disorder	0.000167	0.000217	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADRB2—autistic disorder	0.000167	0.000217	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000165	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—POMC—autistic disorder	0.000165	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000165	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PRKCB—autistic disorder	0.000164	0.000214	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PIK3CG—autistic disorder	0.000164	0.000214	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GABBR1—autistic disorder	0.000163	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADM—autistic disorder	0.000163	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADM—autistic disorder	0.000163	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GABBR1—autistic disorder	0.000163	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADM—autistic disorder	0.000161	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GABBR1—autistic disorder	0.000161	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EIF4E—autistic disorder	0.00016	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EIF4E—autistic disorder	0.00016	0.000208	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PDE4B—autistic disorder	0.000159	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AVP—autistic disorder	0.000159	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PDE4B—autistic disorder	0.000158	0.000206	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000158	0.000206	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EIF4E—autistic disorder	0.000158	0.000206	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AVP—autistic disorder	0.000158	0.000206	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000158	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—DHFR—autistic disorder	0.000158	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PIK3CG—autistic disorder	0.000157	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PDE4B—autistic disorder	0.000157	0.000204	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AVP—autistic disorder	0.000157	0.000204	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—POMC—autistic disorder	0.000156	0.000204	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PRL—autistic disorder	0.000156	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—OPRM1—autistic disorder	0.000154	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—OPRM1—autistic disorder	0.000153	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—OPRM1—autistic disorder	0.000152	0.000198	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—POMC—autistic disorder	0.00015	0.000195	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PRL—autistic disorder	0.000149	0.000194	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PLA2G4A—autistic disorder	0.000149	0.000194	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PLA2G4A—autistic disorder	0.000149	0.000194	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADRB2—autistic disorder	0.000148	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PLA2G4A—autistic disorder	0.000147	0.000192	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR2A—autistic disorder	0.000145	0.000189	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR2A—autistic disorder	0.000145	0.000189	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR2A—autistic disorder	0.000143	0.000187	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADRB2—autistic disorder	0.000142	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GZMB—autistic disorder	0.000141	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GZMB—autistic disorder	0.00014	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GZMB—autistic disorder	0.000139	0.000181	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AVP—autistic disorder	0.000139	0.000181	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF2—autistic disorder	0.000138	0.00018	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR1B—autistic disorder	0.000137	0.000178	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—OXT—autistic disorder	0.000137	0.000178	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR1B—autistic disorder	0.000136	0.000177	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—OXT—autistic disorder	0.000136	0.000177	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR1B—autistic disorder	0.000135	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—OXT—autistic disorder	0.000135	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AVP—autistic disorder	0.000133	0.000173	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF2—autistic disorder	0.000132	0.000173	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR2A—autistic disorder	0.000132	0.000172	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR2A—autistic disorder	0.000132	0.000171	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PLA2G4A—autistic disorder	0.000131	0.00017	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR2A—autistic disorder	0.00013	0.00017	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PRKCB—autistic disorder	0.000127	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—IL2—autistic disorder	0.000127	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MEF2C—autistic disorder	0.000127	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD1—autistic disorder	0.000127	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TSC1—autistic disorder	0.000127	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PRKCB—autistic disorder	0.000127	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD1—autistic disorder	0.000127	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TSC1—autistic disorder	0.000127	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PRKCB—autistic disorder	0.000126	0.000164	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TSC1—autistic disorder	0.000125	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD1—autistic disorder	0.000125	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PLA2G4A—autistic disorder	0.000125	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ITGB3—autistic disorder	0.000124	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NTRK2—autistic disorder	0.000124	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CYP19A1—autistic disorder	0.000124	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NTRK2—autistic disorder	0.000123	0.00016	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD3—autistic disorder	0.000123	0.00016	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD3—autistic disorder	0.000123	0.00016	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NTRK2—autistic disorder	0.000122	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CG—autistic disorder	0.000122	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—IL2—autistic disorder	0.000122	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MEF2C—autistic disorder	0.000122	0.000158	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CG—autistic disorder	0.000122	0.000158	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD3—autistic disorder	0.000122	0.000158	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL5—autistic disorder	0.00012	0.000157	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CG—autistic disorder	0.00012	0.000157	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL5—autistic disorder	0.00012	0.000156	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CALCA—autistic disorder	0.000119	0.000155	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL5—autistic disorder	0.000119	0.000155	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CALCA—autistic disorder	0.000119	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ITGB3—autistic disorder	0.000119	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CALCA—autistic disorder	0.000117	0.000153	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—POMC—autistic disorder	0.000116	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PRKCB—autistic disorder	0.000116	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—POMC—autistic disorder	0.000116	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR2A—autistic disorder	0.000116	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL2—autistic disorder	0.000116	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PRKCB—autistic disorder	0.000115	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—COMT—autistic disorder	0.000115	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—POMC—autistic disorder	0.000115	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTP1—autistic disorder	0.000114	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PRKCB—autistic disorder	0.000114	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MAOA—autistic disorder	0.000114	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CAT—autistic disorder	0.000111	0.000145	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CG—autistic disorder	0.000111	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR2A—autistic disorder	0.000111	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL2—autistic disorder	0.000111	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CG—autistic disorder	0.00011	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TSC2—autistic disorder	0.00011	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CG—autistic disorder	0.000109	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOE—autistic disorder	0.000107	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—LEP—autistic disorder	0.000107	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—POMC—autistic disorder	0.000105	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TSC2—autistic disorder	0.000105	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRL—autistic disorder	0.000105	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—POMC—autistic disorder	0.000105	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PLA2G4A—autistic disorder	0.000105	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTM1—autistic disorder	0.000105	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRL—autistic disorder	0.000105	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—POMC—autistic disorder	0.000104	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRL—autistic disorder	0.000104	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—LEP—autistic disorder	0.000103	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOE—autistic disorder	0.000103	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PRKCB—autistic disorder	0.000101	0.000132	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GPX1—autistic disorder	0.000101	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRB2—autistic disorder	9.97e-05	0.00013	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRB2—autistic disorder	9.94e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRB2—autistic disorder	9.84e-05	0.000128	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PRKCB—autistic disorder	9.71e-05	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APC—autistic disorder	9.7e-05	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CG—autistic disorder	9.7e-05	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGF—autistic disorder	9.59e-05	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AVP—autistic disorder	9.37e-05	0.000122	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AVP—autistic disorder	9.34e-05	0.000122	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF2—autistic disorder	9.33e-05	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF2—autistic disorder	9.3e-05	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APC—autistic disorder	9.29e-05	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CG—autistic disorder	9.29e-05	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MTHFR—autistic disorder	9.28e-05	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AVP—autistic disorder	9.25e-05	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—POMC—autistic disorder	9.23e-05	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF2—autistic disorder	9.21e-05	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGF—autistic disorder	9.18e-05	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF1—autistic disorder	8.88e-05	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—POMC—autistic disorder	8.84e-05	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—MAPK1—autistic disorder	8.84e-05	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PLA2G4A—autistic disorder	8.81e-05	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PLA2G4A—autistic disorder	8.78e-05	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PLA2G4A—autistic disorder	8.7e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—autistic disorder	8.64e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—IL2—autistic disorder	8.58e-05	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MEF2C—autistic disorder	8.57e-05	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—IL2—autistic disorder	8.55e-05	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MEF2C—autistic disorder	8.54e-05	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF1—autistic disorder	8.51e-05	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—IL2—autistic disorder	8.47e-05	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—MAPK1—autistic disorder	8.47e-05	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MEF2C—autistic disorder	8.46e-05	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SERPINE1—autistic disorder	8.44e-05	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ITGB3—autistic disorder	8.35e-05	0.000109	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ITGB3—autistic disorder	8.32e-05	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ITGB3—autistic disorder	8.24e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SERPINE1—autistic disorder	8.08e-05	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CG—autistic disorder	7.8e-05	0.000102	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—autistic disorder	7.8e-05	0.000102	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL2—autistic disorder	7.79e-05	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—autistic disorder	7.77e-05	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL2—autistic disorder	7.77e-05	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—autistic disorder	7.7e-05	0.0001	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL2—autistic disorder	7.69e-05	0.0001	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—POMC—autistic disorder	7.42e-05	9.67e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TSC2—autistic disorder	7.41e-05	9.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TSC2—autistic disorder	7.38e-05	9.61e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TSC2—autistic disorder	7.31e-05	9.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—LEP—autistic disorder	7.25e-05	9.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—autistic disorder	7.25e-05	9.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—autistic disorder	7.23e-05	9.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—LEP—autistic disorder	7.23e-05	9.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—autistic disorder	7.15e-05	9.32e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—LEP—autistic disorder	7.15e-05	9.32e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HRAS—autistic disorder	7.1e-05	9.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PRKCB—autistic disorder	6.84e-05	8.9e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL2—autistic disorder	6.83e-05	8.89e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PRKCB—autistic disorder	6.81e-05	8.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HRAS—autistic disorder	6.8e-05	8.85e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—autistic disorder	6.79e-05	8.84e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCB—autistic disorder	6.75e-05	8.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APC—autistic disorder	6.54e-05	8.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	6.54e-05	8.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL2—autistic disorder	6.54e-05	8.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APC—autistic disorder	6.52e-05	8.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	6.52e-05	8.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—autistic disorder	6.5e-05	8.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGF—autistic disorder	6.47e-05	8.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	6.46e-05	8.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APC—autistic disorder	6.46e-05	8.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGF—autistic disorder	6.45e-05	8.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PTEN—autistic disorder	6.42e-05	8.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGF—autistic disorder	6.38e-05	8.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—POMC—autistic disorder	6.23e-05	8.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—POMC—autistic disorder	6.21e-05	8.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PTEN—autistic disorder	6.15e-05	8.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—POMC—autistic disorder	6.15e-05	8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF1—autistic disorder	5.99e-05	7.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF1—autistic disorder	5.97e-05	7.77e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	5.96e-05	7.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	5.94e-05	7.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—autistic disorder	5.92e-05	7.71e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF1—autistic disorder	5.91e-05	7.7e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	5.88e-05	7.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	5.69e-05	7.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	5.67e-05	7.38e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	5.61e-05	7.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK1—autistic disorder	5.22e-05	6.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTEN—autistic disorder	5.16e-05	6.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK1—autistic disorder	5e-05	6.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HRAS—autistic disorder	4.79e-05	6.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HRAS—autistic disorder	4.77e-05	6.21e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HRAS—autistic disorder	4.72e-05	6.15e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL2—autistic disorder	4.6e-05	5.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL2—autistic disorder	4.59e-05	5.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—autistic disorder	4.58e-05	5.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—autistic disorder	4.57e-05	5.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL2—autistic disorder	4.54e-05	5.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—autistic disorder	4.52e-05	5.89e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTEN—autistic disorder	4.33e-05	5.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTEN—autistic disorder	4.32e-05	5.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTEN—autistic disorder	4.28e-05	5.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HRAS—autistic disorder	4.19e-05	5.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HRAS—autistic disorder	4.01e-05	5.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—autistic disorder	4.01e-05	5.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—autistic disorder	3.84e-05	5e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK1—autistic disorder	3.52e-05	4.58e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK1—autistic disorder	3.51e-05	4.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK1—autistic disorder	3.48e-05	4.53e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HRAS—autistic disorder	2.83e-05	3.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HRAS—autistic disorder	2.82e-05	3.67e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HRAS—autistic disorder	2.79e-05	3.63e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—autistic disorder	2.71e-05	3.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—autistic disorder	2.7e-05	3.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—autistic disorder	2.67e-05	3.48e-05	CbGpPWpGaD
